Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 25.16

From 52W high−15.72%

Volume3.24M

Market capCNY 22.48B

P/E (TTM)12.7x

P/S (TTM)3.9x

Div yield6.91%

Key dataSep 18, 2026

Open

CNY 25.16

From 52W high

−15.72%

Volume

3.24M

Market cap

CNY 22.48B

ValuationView details →

P/E (Fwd)

10.4x

EV/EBITDA

8.1x

P/E (TTM)

12.7x

RSI (14)

47.5

MomentumView details →

1D Return

+0.04%

YTD Return

−4.22%

ValuationView details →

P/E (Fwd)

10.4x

P/E (TTM)

12.7x

EV/EBITDA

8.1x

EV/Sales

3.4x

P/S (TTM)

3.9x

P/B (TTM)

1.7x

ProfitabilityView details →

Gross Margin

80.04%

Net Margin

29.45%

EBITDA Margin

41.83%

ROE (TTM)

11.59%

ROA (TTM)

9.74%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−17.35%

EPS YoY

−18.34%

FCF YoY

−32.76%

Revenue CAGR 3Y

−11.58%

EPS CAGR 3Y

−7.52%

EBITDA YoY

—

MomentumView details →

1D Return

+0.04%

YTD Return

−4.22%

1Y Return

−1.06%

RSI (14)

47.5

vs 50D SMA

−2.03%

vs 200D SMA

−4.70%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

5.46x

Quick Ratio

5.32x

Div Yield

6.91%

Div Rate

CNY 1.74

Div Growth 1Y

−16.75%

EarningsView details →

EPS (Actual)

CNY 0.41

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.47

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

5.90B

Net Income (TTM)

1.74B

Op. CF (TTM)

1.28B

Next earningsOct 26, 2026 →

Latest newsMore news →

Jichuan Pharmaceutical's employee representative director Huang Qurong reduced his shareholding by 96,000 shares on August 31, 2026, completing his reduction plan.19d ago

Similar companies

天士力600535.SH Aprogen Biologics Inc.003060.KS Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited00874.HK The United Laboratories International Holdings Limited03933.HK 华海药业600521.SH 哈药股份600664.SH Find similar companies →

Latest newsMore news →

Jichuan Pharmaceutical's employee representative director Huang Qurong reduced his shareholding by 96,000 shares on August 31, 2026, completing his reduction plan.19d ago